- call +1-201-465-4211
- email sales@mrinsights.biz
Immune globulin derived from the plasma of paid and volunteer donors is used in the treatment of an array of disorders, including primary and secondary immune deficiency states and a variety of autoimmune and inflammatory disorders.
Scope of the Report:
The global Intravenous Immune Globulin Therapies market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Intravenous Immune Globulin Therapies.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Intravenous Immune Globulin Therapies market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Intravenous Immune Globulin Therapies market by product type and applications/end industries.
Market Segment by Companies, this report covers
Baxter
Grifols
CSL Plasma
Octapharma
Biotest
Kedrion
Kamada
China Biologic Products Holdings
Hualan Biological Engineering
Sichuan Yuanda Shuyang Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Liquid Form
Lyophilized Powder Form
Market Segment by Applications, can be divided into
Immunodeficiency
Autoimmune Disease
Acute Infection
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Intravenous Immune Globulin Therapies Market Overview
1.1 Product Overview and Scope of Intravenous Immune Globulin Therapies
1.2 Classification of Intravenous Immune Globulin Therapies by Types
1.2.1 Global Intravenous Immune Globulin Therapies Revenue Comparison by Types (2019-2024)
1.2.2 Global Intravenous Immune Globulin Therapies Revenue Market Share by Types in 2018
1.2.3 Liquid Form
1.2.4 Lyophilized Powder Form
1.3 Global Intravenous Immune Globulin Therapies Market by Application
1.3.1 Global Intravenous Immune Globulin Therapies Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Intravenous Immune Globulin Therapies Market by Regions
1.4.1 Global Intravenous Immune Globulin Therapies Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Intravenous Immune Globulin Therapies Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Intravenous Immune Globulin Therapies Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Intravenous Immune Globulin Therapies Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Intravenous Immune Globulin Therapies Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Intravenous Immune Globulin Therapies Status and Prospect (2014-2024)
1.5 Global Market Size of Intravenous Immune Globulin Therapies (2014-2024)
2 Manufacturers Profiles
2.1 Baxter
2.1.1 Business Overview
2.1.2 Intravenous Immune Globulin Therapies Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Baxter Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.2 Grifols
2.2.1 Business Overview
2.2.2 Intravenous Immune Globulin Therapies Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Grifols Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.3 CSL Plasma
2.3.1 Business Overview
2.3.2 Intravenous Immune Globulin Therapies Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 CSL Plasma Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.4 Octapharma
2.4.1 Business Overview
2.4.2 Intravenous Immune Globulin Therapies Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Octapharma Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.5 Biotest
2.5.1 Business Overview
2.5.2 Intravenous Immune Globulin Therapies Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Biotest Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.6 Kedrion
2.6.1 Business Overview
2.6.2 Intravenous Immune Globulin Therapies Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Kedrion Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.7 Kamada
2.7.1 Business Overview
2.7.2 Intravenous Immune Globulin Therapies Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Kamada Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.8 China Biologic Products Holdings
2.8.1 Business Overview
2.8.2 Intravenous Immune Globulin Therapies Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 China Biologic Products Holdings Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.9 Hualan Biological Engineering
2.9.1 Business Overview
2.9.2 Intravenous Immune Globulin Therapies Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Hualan Biological Engineering Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.10 Sichuan Yuanda Shuyang Pharmaceutical
2.10.1 Business Overview
2.10.2 Intravenous Immune Globulin Therapies Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
3 Global Intravenous Immune Globulin Therapies Market Competition, by Players
3.1 Global Intravenous Immune Globulin Therapies Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Intravenous Immune Globulin Therapies Players Market Share
3.2.2 Top 10 Intravenous Immune Globulin Therapies Players Market Share
3.3 Market Competition Trend
4 Global Intravenous Immune Globulin Therapies Market Size by Regions
4.1 Global Intravenous Immune Globulin Therapies Revenue and Market Share by Regions
4.2 North America Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
4.3 Europe Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
4.5 South America Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
5 North America Intravenous Immune Globulin Therapies Revenue by Countries
5.1 North America Intravenous Immune Globulin Therapies Revenue by Countries (2014-2019)
5.2 USA Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
5.3 Canada Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
5.4 Mexico Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
6 Europe Intravenous Immune Globulin Therapies Revenue by Countries
6.1 Europe Intravenous Immune Globulin Therapies Revenue by Countries (2014-2019)
6.2 Germany Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
6.3 UK Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
6.4 France Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
6.5 Russia Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
6.6 Italy Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Intravenous Immune Globulin Therapies Revenue by Countries
7.1 Asia-Pacific Intravenous Immune Globulin Therapies Revenue by Countries (2014-2019)
7.2 China Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
7.3 Japan Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
7.4 Korea Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
7.5 India Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
8 South America Intravenous Immune Globulin Therapies Revenue by Countries
8.1 South America Intravenous Immune Globulin Therapies Revenue by Countries (2014-2019)
8.2 Brazil Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
8.3 Argentina Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
8.4 Colombia Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Intravenous Immune Globulin Therapies by Countries
9.1 Middle East and Africa Intravenous Immune Globulin Therapies Revenue by Countries (2014-2019)
9.2 Saudi Arabia Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
9.3 UAE Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
9.4 Egypt Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
9.5 Nigeria Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
9.6 South Africa Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
10 Global Intravenous Immune Globulin Therapies Market Segment by Type
10.1 Global Intravenous Immune Globulin Therapies Revenue and Market Share by Type (2014-2019)
10.2 Global Intravenous Immune Globulin Therapies Market Forecast by Type (2019-2024)
10.3 Liquid Form Revenue Growth Rate (2014-2024)
10.4 Lyophilized Powder Form Revenue Growth Rate (2014-2024)
11 Global Intravenous Immune Globulin Therapies Market Segment by Application
11.1 Global Intravenous Immune Globulin Therapies Revenue Market Share by Application (2014-2019)
11.2 Intravenous Immune Globulin Therapies Market Forecast by Application (2019-2024)
11.3 Immunodeficiency Revenue Growth (2014-2019)
11.4 Autoimmune Disease Revenue Growth (2014-2019)
11.5 Acute Infection Revenue Growth (2014-2019)
12 Global Intravenous Immune Globulin Therapies Market Size Forecast (2019-2024)
12.1 Global Intravenous Immune Globulin Therapies Market Size Forecast (2019-2024)
12.2 Global Intravenous Immune Globulin Therapies Market Forecast by Regions (2019-2024)
12.3 North America Intravenous Immune Globulin Therapies Revenue Market Forecast (2019-2024)
12.4 Europe Intravenous Immune Globulin Therapies Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Intravenous Immune Globulin Therapies Revenue Market Forecast (2019-2024)
12.6 South America Intravenous Immune Globulin Therapies Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Intravenous Immune Globulin Therapies Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Intravenous Immune Globulin Therapies Picture
Table Product Specifications of Intravenous Immune Globulin Therapies
Table Global Intravenous Immune Globulin Therapie
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
